JP2003508495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003508495A5 JP2003508495A5 JP2001521339A JP2001521339A JP2003508495A5 JP 2003508495 A5 JP2003508495 A5 JP 2003508495A5 JP 2001521339 A JP2001521339 A JP 2001521339A JP 2001521339 A JP2001521339 A JP 2001521339A JP 2003508495 A5 JP2003508495 A5 JP 2003508495A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- composition according
- vaccine composition
- hsv
- hpv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 24
- 239000000427 antigen Substances 0.000 claims 23
- 102000036639 antigens Human genes 0.000 claims 23
- 108091007433 antigens Proteins 0.000 claims 23
- 229960005486 vaccine Drugs 0.000 claims 23
- 241000701806 Human papillomavirus Species 0.000 claims 6
- 241000700584 Simplexvirus Species 0.000 claims 5
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 241000700721 Hepatitis B virus Species 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 claims 1
- 101100056797 Canis lupus familiaris SAG gene Proteins 0.000 claims 1
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 101100532512 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SAG1 gene Proteins 0.000 claims 1
- 241000223996 Toxoplasma Species 0.000 claims 1
- 108010049895 Toxoplasma SAG1 antigen Proteins 0.000 claims 1
- 241000223997 Toxoplasma gondii Species 0.000 claims 1
- 229940037003 alum Drugs 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 230000036755 cellular response Effects 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 208000005252 hepatitis A Diseases 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9921146.8 | 1999-09-07 | ||
| GB9921146A GB9921146D0 (en) | 1999-09-07 | 1999-09-07 | Novel composition |
| PCT/EP2000/008784 WO2001017551A2 (en) | 1999-09-07 | 2000-09-07 | Combined vaccine compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003296403A Division JP2004067696A (ja) | 1999-09-07 | 2003-08-20 | 新規組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003508495A JP2003508495A (ja) | 2003-03-04 |
| JP2003508495A5 true JP2003508495A5 (enExample) | 2005-06-02 |
| JP4689910B2 JP4689910B2 (ja) | 2011-06-01 |
Family
ID=10860520
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001521339A Expired - Fee Related JP4689910B2 (ja) | 1999-09-07 | 2000-09-07 | 新規組成物 |
| JP2003296403A Pending JP2004067696A (ja) | 1999-09-07 | 2003-08-20 | 新規組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003296403A Pending JP2004067696A (ja) | 1999-09-07 | 2003-08-20 | 新規組成物 |
Country Status (33)
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20060029617A1 (en) * | 1997-10-03 | 2006-02-09 | Charreyre Catherine E | Porcine circovirus and Helicobacter combination vaccines and methods of use |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| ATE335510T1 (de) | 1998-05-22 | 2006-09-15 | Ottawa Health Research Inst | Methoden und produkte zur induzierung mukosaler immunität |
| CZ301212B6 (cs) | 1998-10-16 | 2009-12-09 | Smithkline Beecham Biologicals S. A. | Vakcinacní prostredek |
| US20050002958A1 (en) * | 1999-06-29 | 2005-01-06 | Smithkline Beecham Biologicals Sa | Vaccines |
| GB9921147D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| EP1243655B1 (en) * | 2001-03-23 | 2007-02-21 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Modified HPV E6 and E7 genes and proteins useful for vaccination |
| GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
| GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| PT1506222E (pt) † | 2002-05-17 | 2009-06-12 | Univ Cape Town | Proteínas l1 quiméricas do papilomavírus humano 16 incluindo um péptido l2, partículas semelhantes a vírus preparadas a partir daquelas e um método de preparação das partículas |
| AU2003254585A1 (en) | 2002-07-24 | 2004-02-16 | Intercell Ag | Antigens encoded by alternative reading frame from pathogenic viruses |
| EP1537418A2 (en) | 2002-09-13 | 2005-06-08 | Intercell AG | Method for isolating hepatitis c virus peptides |
| MXPA05004588A (es) | 2002-10-29 | 2005-12-14 | Coley Pharmaceutical Group Ltd | Metodos y productos relacionados con el tratamiento y prevencion de infeccion de virus de hepatitis c. |
| WO2004053104A2 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5’ cpg nucleic acids and methods of use |
| JP5475939B2 (ja) * | 2002-12-20 | 2014-04-16 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｈｐｖ−１６およびｈｐｖ−１８ｌ１ｖｌｐワクチン |
| SI1572233T1 (sl) * | 2002-12-20 | 2011-07-29 | Glaxosmithkline Biolog Sa | Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68 |
| US7858098B2 (en) * | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
| CN100355453C (zh) * | 2003-03-24 | 2007-12-19 | 英特塞尔股份公司 | 改进的疫苗 |
| DE602004029657D1 (de) | 2003-03-24 | 2010-12-02 | Intercell Ag | Verbesserte impfstoffe |
| GB0413510D0 (en) * | 2004-06-16 | 2004-07-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US7758866B2 (en) * | 2004-06-16 | 2010-07-20 | Glaxosmithkline Biologicals, S.A. | Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 |
| JP2008502633A (ja) * | 2004-06-16 | 2008-01-31 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Ｈｐｖ１６およびｈｐｖ１８ならびにｈｐｖ３１、４５または５２から選ばれる少なくとも１つの別のｈｐｖ型に対するワクチン |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| EP1850871A2 (en) * | 2005-02-16 | 2007-11-07 | Novartis Vaccines and Diagnostics, Inc. | Adjuvant composition comprising aluminium phosphate and 3d-mpl |
| JP4182074B2 (ja) | 2005-03-03 | 2008-11-19 | ファナック株式会社 | ハンド及びハンドリングロボット |
| EP1863529A1 (en) * | 2005-03-23 | 2007-12-12 | GlaxoSmithKline Biologicals S.A. | Novel composition |
| SG159529A1 (en) * | 2005-04-26 | 2010-03-30 | Glaxosmithkline Biolog Sa | Vaccine |
| EP1877086A2 (en) * | 2005-04-26 | 2008-01-16 | GlaxoSmithKline Biologicals SA | Vaccine |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| US7790203B2 (en) * | 2005-12-13 | 2010-09-07 | Lowder Tom R | Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions |
| DK2371383T3 (en) | 2005-12-29 | 2015-11-30 | Boehringer Ingelheim Vetmed | Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs |
| EP3320919B1 (en) | 2005-12-29 | 2020-05-27 | Boehringer Ingelheim Animal Health USA Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| US20090246220A1 (en) | 2006-08-28 | 2009-10-01 | Ertl Hildegund C J | Constructs for enhancing immune responses |
| US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US8273361B2 (en) | 2006-09-26 | 2012-09-25 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
| EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
| WO2008112125A1 (en) | 2007-03-09 | 2008-09-18 | Merck & Co., Inc. | Papillomavirus vaccine compositions |
| WO2009001867A1 (ja) * | 2007-06-26 | 2008-12-31 | Japan Health Sciences Foundation | 高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原 |
| US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| KR101507822B1 (ko) | 2008-06-04 | 2015-04-24 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법 |
| RS53607B1 (sr) * | 2008-07-31 | 2015-04-30 | Glaxosmithkline Biologicals S.A. | Vakcina protiv hpv |
| CN106924728B (zh) * | 2009-05-22 | 2021-02-05 | 健诺西生物科学公司 | 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法 |
| LT2437753T (lt) | 2009-06-05 | 2016-12-12 | Infectious Disease Research Institute | Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos |
| AU2009348078B2 (en) * | 2009-06-19 | 2013-03-14 | Eyegene Inc. | Vaccine for cervical cancer |
| PE20120563A1 (es) * | 2009-06-25 | 2012-05-17 | Glaxosmithkline Biolog Sa | Construcciones novedosas de proteina del virus de papiloma humano (hpv) y su uso en la prevencion de la enfermedad por el hpv |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| JP6034285B2 (ja) * | 2010-05-28 | 2016-11-30 | ゾエティス・ベルジャム・エス・アー | 抗原および免疫調節ワクチンおよびコレステロール、ならびにその使用 |
| UA112970C2 (uk) * | 2010-08-05 | 2016-11-25 | Мерк Шарп Енд Доме Корп. | Інактивований вірус вітряної віспи, спосіб його одержання і застосування |
| CA2808285C (en) * | 2010-08-27 | 2016-09-06 | Intervet International B.V. | Potency test for vaccine formulations |
| CN102008721A (zh) * | 2010-11-16 | 2011-04-13 | 浙江大学 | 一种hpv多肽/dc混合疫苗及其制备 |
| WO2012074881A2 (en) | 2010-11-24 | 2012-06-07 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| WO2012141984A1 (en) | 2011-04-08 | 2012-10-18 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
| CN102210858B (zh) * | 2011-05-18 | 2013-05-08 | 北京科兴生物制品有限公司 | 一种肠道病毒71型与甲型肝炎联合疫苗 |
| WO2012177970A1 (en) | 2011-06-24 | 2012-12-27 | Merck Sharp & Dohme Corp. | Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same |
| WO2013006569A2 (en) * | 2011-07-01 | 2013-01-10 | The Regents Of The University Of California | Herpes virus vaccine and methods of use |
| JP6199878B2 (ja) | 2011-11-23 | 2017-09-20 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法 |
| US11510875B2 (en) | 2012-02-07 | 2022-11-29 | Access To Advanced Health Institute | Adjuvant formulations comprising TLR4 agonists and methods of using the same |
| LT2850431T (lt) | 2012-05-16 | 2018-06-25 | Immune Design Corp. | Vakcinos, skirtos hsv-2 |
| US9624510B2 (en) | 2013-03-01 | 2017-04-18 | The Wistar Institute | Adenoviral vectors comprising partial deletions of E3 |
| KR102039520B1 (ko) | 2013-04-18 | 2019-11-01 | 이뮨 디자인 코포레이션 | 암 치료에 이용하기 위한 gla 단일요법 |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| IL310015B1 (en) | 2013-12-31 | 2025-10-01 | Access To Advanced Health Inst | Single vial formulation |
| CN109804075A (zh) | 2016-08-01 | 2019-05-24 | 威斯塔解剖学和生物学研究所 | 用于疫苗应用的复制缺陷型腺病毒载体的组合物和方法 |
| WO2018064232A1 (en) | 2016-09-28 | 2018-04-05 | Genocea Biosciences, Inc. | Methods and compositions for treating herpes |
| CN107987159B (zh) * | 2017-11-28 | 2021-06-22 | 上海药明生物医药有限公司 | 一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法 |
| GB201821207D0 (en) * | 2018-12-24 | 2019-02-06 | Tcer Ab | Immunotherapy therapy |
| CN114340665A (zh) | 2019-05-25 | 2022-04-12 | 传染病研究所 | 用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法 |
| CN110576034B (zh) * | 2019-10-09 | 2020-06-30 | 北京尚华生态环保科技股份公司 | 一种土壤原位修复方法 |
| CN110652980B (zh) * | 2019-10-09 | 2020-06-30 | 北京尚华生态环保科技股份公司 | 一种土壤原位修复剂 |
| WO2021097347A1 (en) | 2019-11-15 | 2021-05-20 | Infectious Disease Research Institute | Rig-i agonist and adjuvant formulation for tumor treatment |
| CN114681602B (zh) * | 2020-12-25 | 2023-12-01 | 中国食品药品检定研究院 | 一种双价人乳头瘤病毒疫苗 |
| CN114796479A (zh) * | 2022-06-02 | 2022-07-29 | 金宇保灵生物药品有限公司 | 一种畜类动物疫苗用水包油包水佐剂及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085804B2 (ja) | 1988-04-28 | 1996-01-24 | 財団法人化学及血清療法研究所 | Ａ型及びｂ型肝炎混合アジュバントワクチン |
| GB9113809D0 (en) * | 1991-06-26 | 1991-08-14 | Cancer Res Campaign Tech | Papillomavirus l2 protein |
| DK1298211T3 (da) * | 1991-07-19 | 2006-11-13 | Univ Queensland | Polynukleotidsegment af HPV16-genom |
| US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
| US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| ES2162139T5 (es) | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
| GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
| CA2211995A1 (en) * | 1995-02-24 | 1996-08-29 | Cantab Pharmaceuticals Research Limited | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| CA2242200A1 (en) * | 1996-01-26 | 1997-07-31 | Innogenetics N.V. | Toxoplasma gondii antigen tg20 |
| KR100365986B1 (ko) * | 1996-02-09 | 2003-02-20 | 스미스클라인 비이참 바이오로지칼즈 에스.에이. | 수두대상포진바이러스유전자63생성물에대한백신 |
| GB9711990D0 (en) * | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| CA2229955C (en) * | 1998-02-20 | 2003-12-09 | Medigene Gmbh | Papilloma virus capsomere vaccine formulations and methods of use |
| KR20010041629A (ko) * | 1998-03-09 | 2001-05-25 | 장 스테판느 | 혼합 백신 조성물 |
| US6500284B1 (en) | 1998-06-10 | 2002-12-31 | Suraltech, Inc. | Processes for continuously producing fine grained metal compositions and for semi-solid forming of shaped articles |
| GB9819898D0 (en) | 1998-09-11 | 1998-11-04 | Smithkline Beecham Plc | New vaccine and method of use |
| CZ301212B6 (cs) | 1998-10-16 | 2009-12-09 | Smithkline Beecham Biologicals S. A. | Vakcinacní prostredek |
| PT1150712E (pt) * | 1999-02-05 | 2008-12-22 | Merck & Co Inc | Formulações para a vacina do vírus do papiloma humano |
| GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
-
1999
- 1999-09-07 GB GB9921146A patent/GB9921146D0/en not_active Ceased
-
2000
- 2000-09-05 MY MYPI20033661A patent/MY142842A/en unknown
- 2000-09-05 AR ARP000104636 patent/AR025502A1/es active IP Right Grant
- 2000-09-05 CO CO00066605A patent/CO5280045A1/es not_active Application Discontinuation
- 2000-09-05 MY MYPI20004083A patent/MY130084A/en unknown
- 2000-09-06 GC GCP2000892 patent/GC0000201A/en active
- 2000-09-07 IL IL15810700A patent/IL158107A0/xx unknown
- 2000-09-07 CN CNB008154244A patent/CN100389824C/zh not_active Expired - Fee Related
- 2000-09-07 DE DE2000624893 patent/DE60024893T2/de not_active Expired - Lifetime
- 2000-09-07 EP EP20000967654 patent/EP1210113B1/en not_active Expired - Lifetime
- 2000-09-07 DK DK03078635T patent/DK1410805T3/da active
- 2000-09-07 BR BR0014171A patent/BR0014171A/pt not_active IP Right Cessation
- 2000-09-07 ES ES03078635T patent/ES2253636T3/es not_active Expired - Lifetime
- 2000-09-07 EP EP20060075129 patent/EP1769806A3/en not_active Withdrawn
- 2000-09-07 EP EP20030078635 patent/EP1410805B1/en not_active Expired - Lifetime
- 2000-09-07 ES ES00967654T patent/ES2261243T3/es not_active Expired - Lifetime
- 2000-09-07 CZ CZ2002843A patent/CZ2002843A3/cs unknown
- 2000-09-07 ZA ZA200306402A patent/ZA200306402B/xx unknown
- 2000-09-07 JP JP2001521339A patent/JP4689910B2/ja not_active Expired - Fee Related
- 2000-09-07 KR KR1020037013500A patent/KR100594668B1/ko not_active Expired - Lifetime
- 2000-09-07 PL PL362069A patent/PL201264B1/pl unknown
- 2000-09-07 CA CA 2384064 patent/CA2384064C/en not_active Expired - Fee Related
- 2000-09-07 CA CA 2443214 patent/CA2443214C/en not_active Expired - Lifetime
- 2000-09-07 US US10/070,479 patent/US6936255B1/en not_active Expired - Fee Related
- 2000-09-07 WO PCT/EP2000/008784 patent/WO2001017551A2/en not_active Ceased
- 2000-09-07 KR KR1020027003023A patent/KR100557665B1/ko not_active Expired - Fee Related
- 2000-09-07 CN CNB2004100489635A patent/CN1325117C/zh not_active Expired - Lifetime
- 2000-09-07 SI SI200030859T patent/SI1210113T1/sl unknown
- 2000-09-07 DK DK00967654T patent/DK1210113T3/da active
- 2000-09-07 NZ NZ517621A patent/NZ517621A/en unknown
- 2000-09-07 AU AU77751/00A patent/AU766494B2/en not_active Ceased
- 2000-09-07 HK HK02108383.6A patent/HK1048435B/en not_active IP Right Cessation
- 2000-09-07 DE DE2000627029 patent/DE60027029T2/de not_active Expired - Lifetime
- 2000-09-07 HU HU0202804A patent/HU228687B1/hu not_active IP Right Cessation
- 2000-09-07 MX MXPA02002484A patent/MXPA02002484A/es active IP Right Grant
- 2000-09-07 PT PT00967654T patent/PT1210113E/pt unknown
- 2000-09-07 CZ CZ20032326A patent/CZ302811B6/cs not_active IP Right Cessation
- 2000-09-07 NZ NZ52756000A patent/NZ527560A/xx not_active IP Right Cessation
- 2000-09-07 PL PL354039A patent/PL201767B1/pl not_active IP Right Cessation
- 2000-09-07 SG SG200305672A patent/SG110072A1/en unknown
- 2000-09-07 AT AT00967654T patent/ATE321569T1/de active
- 2000-09-07 AT AT03078635T patent/ATE312624T1/de active
- 2000-09-07 SI SI200030796T patent/SI1410805T1/sl unknown
- 2000-09-07 IL IL14845600A patent/IL148456A0/xx not_active IP Right Cessation
- 2000-09-07 HU HU0303215A patent/HU229099B1/hu unknown
- 2000-09-07 TR TR200200607T patent/TR200200607T2/xx unknown
- 2000-09-19 TW TW92125370A patent/TWI258374B/zh not_active IP Right Cessation
-
2002
- 2002-03-05 ZA ZA200201810A patent/ZA200201810B/xx unknown
- 2002-03-06 NO NO20021116A patent/NO332800B1/no not_active IP Right Cessation
-
2003
- 2003-08-20 JP JP2003296403A patent/JP2004067696A/ja active Pending
- 2003-08-21 NO NO20033715A patent/NO331825B1/no not_active IP Right Cessation
- 2003-09-25 IL IL158107A patent/IL158107A/en active IP Right Grant
- 2003-12-12 US US10/734,857 patent/US7101560B2/en not_active Expired - Lifetime
-
2006
- 2006-02-01 CY CY061100126T patent/CY1107457T1/el unknown
- 2006-06-05 CY CY20061100713T patent/CY1106090T1/el unknown
- 2006-06-29 US US11/477,879 patent/US7220551B2/en not_active Expired - Lifetime
-
2012
- 2012-10-08 NO NO2012016C patent/NO2012016I1/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003508495A5 (enExample) | ||
| CA2384064A1 (en) | Vaccine against herpes simplex virus and human papilloma virus | |
| CA2381047A1 (en) | Vaccine against hepatitis b virus and human papilloma virus | |
| CA2324289A1 (en) | Combined vaccine compositions | |
| AU2003236490B2 (en) | Novel composition | |
| HK1099204A (en) | Vaccine against hbv and hpv | |
| HK1107519A (en) | Vaccine against hpv | |
| MXPA00008817A (en) | Combined vaccine compositions |